JP Morgan Chase
PFE icon

JP Morgan Chase’s Pfizer PFE Stock Holding History

JP Morgan Chase’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107M Buy
3,837,400
+1,207,900
+46% +$32.2M 0.01% 951
2025
Q4 		$65.5M Buy
2,629,500
+323,600
+14% +$8.16M ﹤0.01% 1193
2025
Q3 		$58.8M Buy
2,305,900
+978,500
+74% +$24.2M ﹤0.01% 1310
2025
Q2 		$32.2M Sell
1,327,400
-2,869,900
-68% -$66.9M ﹤0.01% 1614
2025
Q1 		$106M Buy
4,197,300
+937,900
+29% +$24.5M 0.01% 899
2024
Q4 		$86.5M Buy
3,259,400
+2,228,000
+216% +$60.4M 0.01% 1007
2024
Q3 		$29.8M Buy
1,031,400
+305,300
+42% +$8.91M ﹤0.01% 1686
2024
Q2 		$20.3M Sell
726,100
-190,900
-21% -$5.26M ﹤0.01% 1864
2024
Q1 		$25.4M Buy
917,000
+79,800
+10% +$2.21M ﹤0.01% 1727
2023
Q4 		$24.1M Buy
837,200
+478,300
+133% +$14.5M ﹤0.01% 1690
2023
Q3 		$11.9M Sell
358,900
-57,800
-14% -$2.04M ﹤0.01% 2100
2023
Q2 		$15.3M Buy
416,700
+206,500
+98% +$8.04M ﹤0.01% 1914
2023
Q1 		$8.58M Sell
210,200
-536,000
-72% -$23.2M ﹤0.01% 2407
2022
Q4 		$38.2M Buy
746,200
+175,400
+31% +$8.41M 0.01% 1248
2022
Q3 		$25M Sell
570,800
-61,100
-10% -$2.97M ﹤0.01% 1433
2022
Q2 		$33.1M Sell
631,900
-192,400
-23% -$9.8M ﹤0.01% 1271
2022
Q1 		$42.7M Sell
824,300
-93,200
-10% -$4.84M 0.01% 1253
2021
Q4 		$54.2M Buy
917,500
+196,400
+27% +$9.73M 0.01% 1168
2021
Q3 		$31M Buy
721,100
+644,300
+839% +$28.5M ﹤0.01% 1456
2021
Q2 		$3.01M Sell
76,800
-10,000
-12% -$389K ﹤0.01% 3486
2021
Q1 		$3.15M Sell
86,800
-1,519,708
-95% -$54M ﹤0.01% 3359
2020
Q4 		$59.1M Sell
1,606,508
-376,804
-19% -$13.8M 0.01% 1005
2020
Q3 		$68.1M Buy
1,983,312
+1,192,496
+151% +$41.8M 0.01% 841
2020
Q2 		$24.5M Buy
790,816
+575,273
+267% +$19.5M ﹤0.01% 1243
2020
Q1 		$6.67M Sell
215,543
-45,322
-17% -$1.54M ﹤0.01% 2046
2019
Q4 		$9.7M Sell
260,865
-247,690
-49% -$8.82M ﹤0.01% 2140
2019
Q3 		$17.3M Sell
508,555
-255,595
-33% -$9.29M ﹤0.01% 1704
2019
Q2 		$31.5M Sell
764,150
-642,624
-46% -$25.5M 0.01% 1247
2019
Q1 		$56.7M Buy
1,406,774
+914,451
+186% +$36.6M 0.01% 891
2018
Q4 		$20.4M Buy
492,323
+59,024
+14% +$2.45M ﹤0.01% 1478
2018
Q3 		$18.1M Sell
433,299
-147,982
-25% -$5.7M ﹤0.01% 1742
2018
Q2 		$20M Buy
581,281
+330,324
+132% +$11.3M ﹤0.01% 1581
2018
Q1 		$8.45M Sell
250,957
-567,579
-69% -$19.5M ﹤0.01% 2143
2017
Q4 		$28.1M Sell
818,536
-863,753
-51% -$29.5M 0.01% 1333
2017
Q3 		$56.8M Buy
1,682,289
+1,262,692
+301% +$40.6M 0.01% 862
2017
Q2 		$13.4M Sell
419,597
-385,132
-48% -$12.1M ﹤0.01% 1748
2017
Q1 		$26.1M Sell
804,729
-164,951
-17% -$5.2M 0.01% 1289
2016
Q4 		$29.9M Sell
969,680
-2,758,038
-74% -$84.2M 0.01% 1204
2016
Q3 		$120M Sell
3,727,718
-94,754
-2% -$3.17M 0.03% 505
2016
Q2 		$128M Sell
3,822,472
-3,049,924
-44% -$97.3M 0.03% 494
2016
Q1 		$193M Buy
6,872,396
+4,959,808
+259% +$142M 0.05% 379
2015
Q4 		$58.6M Buy
1,912,588
+1,238,734
+184% +$39M 0.01% 743
2015
Q3 		$20.1M Sell
673,854
-3,289,291
-83% -$105M 0.01% 1254
2015
Q2 		$126M Buy
3,963,145
+2,222,359
+128% +$72.4M 0.03% 525
2015
Q1 		$57.5M Sell
1,740,786
-1,435,232
-45% -$45.6M 0.01% 833
2014
Q4 		$93.9M Buy
3,176,018
+679,724
+27% +$19.5M 0.02% 662
2014
Q3 		$70M Buy
+2,496,294
New +$70.1M 0.02% 762
2014
Q2 		– Sell
-1,001,300
Closed -$30.5M – 3605
2014
Q1 		$30.5M Sell
1,001,300
-1,080,982
-52% -$32.2M 0.01% 1088
2013
Q4 		$60.5M Buy
2,082,282
+708,097
+52% +$20.6M 0.02% 719
2013
Q3 		$37.5M Sell
1,374,185
-186,453
-12% -$5.07M 0.01% 956
2013
Q2 		$41.5M Buy
+1,560,638
New +$43.1M 0.01% 826

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase's PFE Position: Q1 2026 in Review

JP Morgan Chase increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $121M and bringing the position to 27,894,042 shares worth $775M. The position accounts for 0.05% of the portfolio, ranked #312.

JP Morgan Chase first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.92B in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • JP Morgan Chase held 27,894,042 shares of Pfizer worth $775M as of Q1 2026.
  • JP Morgan Chase bought 4,552,595 Pfizer shares in Q1 2026, an estimated $121M.
  • Pfizer made up 0.05% of JP Morgan Chase's portfolio in Q1 2026, its #312 holding.
  • JP Morgan Chase first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Pfizer position peaked at $4.92B in Q3 2018.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.